GlassScriptPhysician profile
James Marvin Sturm
NPI 1750441374
$5,772.80
in general payments reported to CMS, 2019-2025
38 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,379 · 2020: $837 · 2021: $952 · 2022: $369 · 2023: $361 · 2024: $527 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,482.87 | 2019-2025 | Relistor |
| Abbott Laboratories | $1,156.14 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $627.91 | 2019-2025 | Xtampza, Belbuca |
| Horizon Therapeutics Plc | $437.72 | 2019-2021 | |
| Abbvie INC. | $403.85 | 2021-2024 | Qulipta |
| Arbor Pharmaceuticals, INC. | $277.14 | 2019-2022 | |
| Pfizer INC. | $146.26 | 2019-2025 | |
| Novo Nordisk INC | $108.87 | 2019 | |
| Novartis Pharmaceuticals Corporation | $104.27 | 2019-2020 | |
| Valinor Pharma, LLC | $89.39 | 2023-2024 | Movantik |
| Tersera Therapeutics LLC | $83.99 | 2019 | |
| Scilex Pharmaceuticals INC. | $69.44 | 2019 | |
| Daiichi Sankyo INC. | $69.42 | 2019 | |
| Virtus Pharmaceuticals LLC | $65.91 | 2021 | |
| Amgen INC. | $50.94 | 2020-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sturm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.